Victory Capital Management
CMTA

Victory Capital Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Victory Capital Management’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-34,710
Closed -$659K – 1963
2017
Q4 		$659K Buy
34,710
+3,920
+13% +$65.6K ﹤0.01% 1295
2017
Q3 		$520K Buy
+30,790
New +$503K ﹤0.01% 1324

Other funds holding CMTA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Victory Capital Management's CMTA Position: Q1 2018 in Review

Victory Capital Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q1 2018, closing a stake of 34,710 shares — an estimated $659K sold.

Victory Capital Management first reported a position in CMTA in Q3 2017 and held it in 2 quarters. The position peaked at $659K in Q4 2017. 38 funds tracked by Wall St. Rank hold CMTA as of Q1 2018.

  • Victory Capital Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • Victory Capital Management sold 34,710 Clementia Pharmaceuticals Inc. shares in Q1 2018, an estimated $659K.
  • Victory Capital Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 2 quarters.
  • Victory Capital Management's Clementia Pharmaceuticals Inc. position peaked at $659K in Q4 2017.
  • 38 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q1 2018.

Based on Victory Capital Management's 13F filing for Q1 2018, filed 4 May 2018.